ATC code C07

ATC code C07 Beta blocking agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C07 is part of the anatomical group C Cardiovascular system.

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC07. ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

C07A Beta blocking agents

C07AA Beta blocking agents, non-selective

C07AA01 Alprenolol

C07AA02 Oxprenolol

C07AA03 Pindolol

C07AA05 Propranolol

C07AA06 Timolol

C07AA07 Sotalol

C07AA12 Nadolol

C07AA14 Mepindolol

C07AA15 Carteolol

C07AA16 Tertatolol

C07AA17 Bopindolol

C07AA19 Bupranolol

C07AA23 Penbutolol

C07AA27 Cloranolol

QC07AA90 Carazolol

C07AB Beta blocking agents, selective

C07AB01 Practolol

C07AB02 Metoprolol

C07AB03 Atenolol

C07AB04 Acebutolol

C07AB05 Betaxolol

C07AB06 Bevantolol

C07AB07 Bisoprolol

C07AB08 Celiprolol

C07AB09 Esmolol

C07AB10 Epanolol

C07AB11 S-atenolol

C07AB12 Nebivolol

C07AB13 Talinolol

C07AB14 Landiolol

C07AG Alpha and beta blocking agents

C07AG01 Labetalol

C07AG02 Carvedilol

C07B Beta blocking agents and thiazides

C07BA Beta blocking agents, non-selective, and thiazides

C07BA02 Oxprenolol and thiazides

C07BA05 Propranolol and thiazides

C07BA06 Timolol and thiazides

C07BA07 Sotalol and thiazides

C07BA12 Nadolol and thiazides

C07BA68 Metipranolol and thiazides, combinations

C07BB Beta blocking agents, selective, and thiazides

C07BB02 Metoprolol and thiazides

C07BB03 Atenolol and thiazides

C07BB04 Acebutolol and thiazides

C07BB06 Bevantolol and thiazides

C07BB07 Bisoprolol and thiazides

C07BB12 Nebivolol and thiazides

C07BB52 Metoprolol and thiazides, combinations

C07BG Alpha and beta blocking agents and thiazides

C07BG01 Labetalol and thiazides

C07C Beta blocking agents and other diuretics

C07CA Beta blocking agents, non-selective, and other diuretics

C07CA02 Oxprenolol and other diuretics

C07CA03 Pindolol and other diuretics

C07CA17 Bopindolol and other diuretics

C07CA23 Penbutolol and other diuretics

C07CB Beta blocking agents, selective, and other diuretics

C07CB02 Metoprolol and other diuretics

C07CB03 Atenolol and other diuretics

C07CB53 Atenolol and other diuretics, combinations

C07CG Alpha and beta blocking agents and other diuretics

C07CG01 Labetalol and other diuretics

C07D Beta blocking agents, thiazides and other diuretics

C07DA Beta blocking agents, non-selective, thiazides and other diuretics

C07DA06 Timolol, thiazides and other diuretics

C07DB Beta blocking agents, selective, thiazides and other diuretics

C07DB01 Atenolol, thiazides and other diuretics

C07E Beta blocking agents and vasodilators

C07EA Beta blocking agents, non-selective, and vasodilators

C07EB Beta blocking agents, selective, and vasodilators

C07F Beta blocking agents, other combinations

C07FB Beta blocking agents and calcium channel blockers

C07FB02 Metoprolol and felodipine

C07FB03 Atenolol and nifedipine

C07FB07 Bisoprolol and amlodipine

C07FB12 Nebivolol and amlodipine

C07FB13 Metoprolol and amlodipine

C07FX Beta blocking agents, other combinations

C07FX01 Propranolol and other combinations

C07FX02 Sotalol and acetylsalicylic acid

C07FX03 Metoprolol and acetylsalicylic acid

C07FX04 Bisoprolol and acetylsalicylic acid

C07FX05 Metoprolol and ivabradine

C07FX06 Carvedilol and ivabradine

References

↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
↑ "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
↑ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
↑ "ATC/DDD Index 2022: code C07". WHO Collaborating Centre for Drug Statistics Methodology.
↑ "ATCvet Index 2022: code QC07". WHO Collaborating Centre for Drug Statistics Methodology.

[1] "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.

[2] "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.

[3] "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.

[4] "ATC/DDD Index 2022: code C07". WHO Collaborating Centre for Drug Statistics Methodology.

[5] "ATCvet Index 2022: code QC07". WHO Collaborating Centre for Drug Statistics Methodology.

v t e Beta blockers (C07)
β, non-selective	Alprenolol Bopindolol Bupranolol Carteolol Cloranolol Mepindolol Nadolol Oxprenolol Penbutolol Pindolol/Iodopindolol Propranolol^# Sotalol Tertatolol Timolol^#
β₁-selective	Acebutolol Atenolol Betaxolol Bevantolol Bisoprolol^# Celiprolol Epanolol Esmolol Landiolol Metoprolol Nebivolol Practolol Talinolol
β₂-selective	Butaxamine
α₁- + β-selective	Arotinolol Carvedilol Labetalol
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III

ATC code C: Cardiovascular system
C01 Cardiac therapy C02 Antihypertensives C03 Diuretics C04 Peripheral vasodilators C05 Vasoprotectives C07 Beta blocking agents C08 Calcium channel blockers C09 Agents acting on the renin–angiotensin system C10 Lipid modifying agents
Other ATC codes
A B C D G H QI J L M N P R S V